{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T13:22:49Z","timestamp":1779196969684,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T00:00:00Z","timestamp":1604880000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ctro.2020.11.004","type":"journal-article","created":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T12:16:56Z","timestamp":1605183416000},"page":"42-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["The safety and efficacy of a novel hypo-fractionated total marrow and lymphoid irradiation before allogeneic stem cell transplantation for lymphoma and acute leukemia"],"prefix":"10.1016","volume":"26","author":[{"given":"Liu","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongli","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiuling","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conghua","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ctro.2020.11.004_b0005","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-018-1116-9","article-title":"Effect of dose rate on pulmonary toxicity in patients with hematolymphoid malignancies undergoing total body irradiation","volume":"13","author":"Kim","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2020.11.004_b0010","doi-asserted-by":"crossref","unstructured":"Ishibashi N, Soejima T, Kawaguchi H, et al. National survey of myeloablative total body irradiation prior to hematopoietic stem cell transplantation in Japan: survey of the Japanese Radiation Oncology Study Group (JROSG). J Radiat Res. 2018; 59: 477-483.","DOI":"10.1093\/jrr\/rry017"},{"issue":"6","key":"10.1016\/j.ctro.2020.11.004_b0015","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.rpor.2012.07.013","article-title":"Dose distribution homogeneity in two TBI techniques\u2014Analysis of 208 irradiated patients conducted in Stanislaw Leszczynski Memorial Hospital, Katowice","volume":"17","author":"Kawa-Iwanicka","year":"2012","journal-title":"Rep Pract Oncol Radiother"},{"issue":"4","key":"10.1016\/j.ctro.2020.11.004_b0020","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.adro.2016.07.001","article-title":"Myeloablative conditioning with total body irradiation for AML: Balancing survival and pulmonary toxicity","volume":"1","author":"Stephens","year":"2016","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ctro.2020.11.004_b0025","doi-asserted-by":"crossref","unstructured":"Studinski RCN, Fraser DJ, Samant RS, et al. Current practice in total-body irradiation: results of a Canada-wide survey. Curr Oncol. 2017; 24: 181-186.","DOI":"10.3747\/co.24.3484"},{"key":"10.1016\/j.ctro.2020.11.004_b0030","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13045-014-0098-9","article-title":"Non-myeloablative allogeneic hematopoietic cell transplantation following fludarabine plus 2 Gy TBI or ATG plus 8 Gy TLI: a phase II randomized study from the Belgian Hematological Society","volume":"8","author":"Baron","year":"2015","journal-title":"J Hematol Oncol."},{"key":"10.1016\/j.ctro.2020.11.004_b0035","doi-asserted-by":"crossref","unstructured":"Mabuchi Y, Takiguchi Y, Yahata T, et al. Short term outcomes of helical tomotherapy during concurrent chemoradiotherapy for advanced cervical cancer. Mol Clin Oncol. 2019; 10: 382-386.","DOI":"10.3892\/mco.2019.1806"},{"key":"10.1016\/j.ctro.2020.11.004_b0040","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5114\/wo.2012.27332","article-title":"Tomotherapy \u2013 a different way of dose delivery in radiotherapy","volume":"1","author":"Piotrowski","year":"2012","journal-title":"wo"},{"issue":"1","key":"10.1016\/j.ctro.2020.11.004_b0045","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-018-1201-0","article-title":"Feasibility of a novel dose fractionation strategy in TMI\/TMLI","volume":"13","author":"Bao","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2020.11.004_b0050","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.bbmt.2017.01.067","article-title":"Phase I trial of total marrow and lymphoid irradiation transplant conditioning in patients with relapsed\/refractory acute leukemia","volume":"23","author":"Stein","year":"2017","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1016\/j.ctro.2020.11.004_b0055","first-page":"1","article-title":"Total Marrow Irradiation as Part of Autologous Stem Cell Transplantation for Asian Patients with Multiple Myeloma","volume":"2013","author":"Lin","year":"2013","journal-title":"Biomed Res Int"},{"issue":"4","key":"10.1016\/j.ctro.2020.11.004_b0060","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.ijrobp.2006.10.047","article-title":"Image-guided total marrow and total lymphatic irradiation using helical tomotherapy","volume":"67","author":"Schultheiss","year":"2007","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"key":"10.1016\/j.ctro.2020.11.004_b0065","doi-asserted-by":"crossref","unstructured":"Rosenthal J, Wong JY, Stein A, et al. Phase 1\/2 trial of total marrow and lymph node irradiation to augment reduced-intensity transplantation for advanced hematologic malignancies. Blood, 2011; 117, 309-315.","DOI":"10.1182\/blood-2010-06-288357"},{"key":"10.1016\/j.ctro.2020.11.004_b0070","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ijrobp.2008.04.071","article-title":"Image-guided total-marrow irradiation using helical tomotherapy in patients with multiple myeloma and acute leukemia undergoing hematopoietic cell transplantation","volume":"73","author":"Wong","year":"2009","journal-title":"Int J Radiation Oncology Biol Phys."},{"key":"10.1016\/j.ctro.2020.11.004_b0075","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1080\/02841860601042449","article-title":"Helical tomotherapy targeting total bone marrow-first clinical experience at the University of Minnesota","volume":"46","author":"Hui","year":"2007","journal-title":"Acta Oncol."},{"issue":"1","key":"10.1016\/j.ctro.2020.11.004_b0080","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.radonc.2015.11.012","article-title":"Marrow damage and hematopoietic recovery following allogeneic bone marrow transplantation for acute leukemias: Effect of radiation dose and conditioning regimen","volume":"118","author":"Wilke","year":"2016","journal-title":"Radiother Oncol"},{"issue":"7","key":"10.1016\/j.ctro.2020.11.004_b0085","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.bbmt.2017.04.002","article-title":"Dose Escalation of Total Marrow Irradiation in High-Risk Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation","volume":"23","author":"Hui","year":"2017","journal-title":"Biol Blood Marrow Transpl"},{"key":"10.1016\/j.ctro.2020.11.004_b0090","doi-asserted-by":"crossref","unstructured":"Magome T, Froelich J, Holtan SG, et al. Whole-body distribution of leukemia and functional total marrow irradiation based on FLT-PET and dual-energy CT. Mol Imaging. 2017; 16: 1536012117732203.","DOI":"10.1177\/1536012117732203"},{"issue":"16","key":"10.1016\/j.ctro.2020.11.004_b0095","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1056\/NEJM197504172921605","article-title":"Bone-Marrow Transplantation: (First of Two Parts)","volume":"292","author":"Thomas","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ctro.2020.11.004_b0100","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/0360-3016(90)90220-E","article-title":"Fractionated total body irradiation and bone marrow transplantation in acute lymphoblastic leukemia","volume":"19","author":"Altschuler","year":"1990","journal-title":"Int J Radiation Oncology Biol Phys"},{"key":"10.1016\/j.ctro.2020.11.004_b0105","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/0360-3016(91)90081-E","article-title":"What does total body irradiation do in bone marrow transplants for leukemia?","volume":"20","author":"Gale","year":"1991","journal-title":"Int J Radiation Oncology Biol Phys"},{"key":"10.1016\/j.ctro.2020.11.004_b0110","unstructured":"Inoue T, Shibata H, Masaoka T. Role of total body irradiation based on the comparative study of preparation regimens for allogeneic bone marrow transplantation for acute leukemia in first remission (Meeting abstract). Int Congress of Radiat Oncol, Kyoto, Japan, 1993: 169."},{"key":"10.1016\/j.ctro.2020.11.004_b0115","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.critrevonc.2018.01.011","article-title":"Total body irradiation in allogeneic bone marrow transplantation conditioning regimens: a review","volume":"123","author":"Paix","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ctro.2020.11.004_b0120","article-title":"A safety and efficacy study of medium-dose etoposide, cyclophosphamide and total body irradiation conditioning before allogeneic stem cell transplantation for acute lymphoblastic leukemia","volume":"1","author":"Shigematsu","year":"2015","journal-title":"Transplant Direct"},{"key":"10.1016\/j.ctro.2020.11.004_b0125","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0360-3016(82)90083-9","article-title":"Marrow transplantation for acute nonlymphoblastic leukemic in first remission using fractionated or single-dose irradiation","volume":"8","author":"Thomas","year":"1982","journal-title":"Int J Radiation Oncology Biol Phys"},{"key":"10.1016\/j.ctro.2020.11.004_b0130","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0360-3016(91)90048-9","article-title":"Influence of the fractionation of total body irradiation on complications and relapse rate for chronic myelogenous leukemia. The Groupe d\u2019Etude des greffes de moelle osseuse (GEGMO)","author":"Socie","year":"1991","journal-title":"Int J Radiation Oncology Biol Phys"},{"key":"10.1016\/j.ctro.2020.11.004_b0135","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1182\/blood.V77.8.1660.1660","article-title":"Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: a randomized trial of two irradiation regimens","volume":"77","author":"Clift","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.ctro.2020.11.004_b0140","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1182\/blood.V76.9.1867.1867","article-title":"Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens","volume":"76","author":"Clift","year":"1990","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.ctro.2020.11.004_b0145","article-title":"A safety and efficacy study of medium-dose etoposide, cyclophosphamide and total body irradiation conditioning before allogeneic stem cell transplantation for acute lymphoblastic leukemia","volume":"1","author":"Shigematsu","year":"2015","journal-title":"Transplant Direct"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630820300914?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630820300914?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:08:50Z","timestamp":1762502930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630820300914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":29,"alternative-id":["S2405630820300914"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2020.11.004","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The safety and efficacy of a novel hypo-fractionated total marrow and lymphoid irradiation before allogeneic stem cell transplantation for lymphoma and acute leukemia","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2020.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}]}}